Baudax Bio

(NASDAQ) BXRX

Current PriceN/A

Market CapN/A

Since IPO (2019)-100%

5 Year-100%

1 Year-99%

1 Month+0%

Baudax Bio Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$326.00K

Net Income (TTM)

-$7.15M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 18, 2024

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 18, 2024

BXRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Baudax Bio

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Gerri Henwood

Website

www.baudaxbio.com

Headquarters

Malvern, PA 19355, US

BXRX Financials

Key Financial Metrics (TTM)

Gross Margin

-5%

Operating Margin

-45%

Net Income Margin

-46%

Return on Equity

11%

Return on Capital

Return on Assets

-6%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$5.74M

Operating Income

-$35.74M

EBITDA

-$35.58M

Operating Cash Flow

-$27.79M

Capital Expenditure

-$20.00K

Free Cash Flow

-$27.81M

Cash & ST Invst.

$5.26M

Total Debt

$7.12M

Baudax Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$43.00K

+95.6%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$1.93M

+93.4%

EBITDA

-$43.00K

+99.3%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$363.00K

-93.6%

Total Debt

$8.10M

+0.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$2.53M

+16.2%

Short Term Debt

$5.57M

-5.8%

Return on Assets

-5.86%

N/A

Return on Invested Capital

4.97%

N/A

Free Cash Flow

-$2.41M

+38.3%

Operating Cash Flow

-$2.41M

+37.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NVIVInVivo Therapeutics Holdings Corporation

NVIVInVivo Therapeutics Holdings Corporation$0.32-34.28%

NMTRQ9 Meters Biopharma, Inc.

NMTRQ9 Meters Biopharma, Inc.$0.00+0.00%

INFIQInfinity Pharmaceuticals, Inc.

INFIQInfinity Pharmaceuticals, Inc.$0.00+0.00%

CWBRCohBar, Inc.

CWBRCohBar, Inc.$0.41+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About BXRX

What is the current price of Baudax Bio?

Baudax Bio is trading at N/A per share.

What is the 52-week range for Baudax Bio?

Over the past 52 weeks, Baudax Bio has traded between N/A and N/A.

How much debt does Baudax Bio have?

As of the most recent reporting period, Baudax Bio reported total debt of $7.12M.

How much cash does Baudax Bio have on hand?

Baudax Bio reported $5.26M in cash and cash equivalents in its most recent financial results.

What is Baudax Bio’s dividend yield?

Baudax Bio does not currently have a dividend yield.

Baudax Bio

Baudax Bio Financials at a Glance

BXRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Baudax Bio

BXRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Baudax Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BXRX

What is the current price of Baudax Bio?

What is the 52-week range for Baudax Bio?

How much debt does Baudax Bio have?

How much cash does Baudax Bio have on hand?

What is Baudax Bio’s dividend yield?

Premium Investing Services